Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavirTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Basic & Clinical Pharmacology & Toxicology|April 22, 2010
Grapefruit juice enhances the exposure to oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Plos One|November 13, 2012
Statins and hip fracture prevention--a population based cohort study in womenArja Helin-Salmivaara, Maarit J Korhonen, Petri Lehenkari, et al.
European Journal of Clinical Pharmacology|October 7, 2008
Voriconazole drastically increases exposure to oral oxycodoneNora M Hagelberg, Tuija H Nieminen, Teijo I Saari, et al.
Clinical and Translational Science|October 31, 2019
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug InteractionTuija Tapaninen, Aleksi M Olkkola, Aleksi Tornio, et al.
European Journal of Pain (London, England)|January 29, 2010
St John's wort greatly reduces the concentrations of oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pharmacogenetics and Genomics|January 15, 2008
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphismsSamuel Fanta, Mikko Niemi, Siv Jönsson, et al.
Fundamental & Clinical Pharmacology|November 24, 2007
Effect of voriconazole on the pharmacokinetics of diclofenacVille-Veikko Hynninen, Klaus T Olkkola, Kari Leino, et al.
European Journal of Pain (London, England)|November 10, 2009
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamineNora M Hagelberg, Marko A Peltoniemi, Teijo I Saari, et al.
European Journal of Clinical Pharmacology|December 18, 2012
Rifampicin markedly decreases the exposure to oral and intravenous tramadolTuukka Saarikoski, Teijo I Saari, Nora M Hagelberg, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavirTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Basic & Clinical Pharmacology & Toxicology|April 22, 2010
Grapefruit juice enhances the exposure to oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Plos One|November 13, 2012
Statins and hip fracture prevention--a population based cohort study in womenArja Helin-Salmivaara, Maarit J Korhonen, Petri Lehenkari, et al.
European Journal of Clinical Pharmacology|October 7, 2008
Voriconazole drastically increases exposure to oral oxycodoneNora M Hagelberg, Tuija H Nieminen, Teijo I Saari, et al.
Clinical and Translational Science|October 31, 2019
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug InteractionTuija Tapaninen, Aleksi M Olkkola, Aleksi Tornio, et al.
European Journal of Pain (London, England)|January 29, 2010
St John's wort greatly reduces the concentrations of oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pharmacogenetics and Genomics|January 15, 2008
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphismsSamuel Fanta, Mikko Niemi, Siv Jönsson, et al.
Fundamental & Clinical Pharmacology|November 24, 2007
Effect of voriconazole on the pharmacokinetics of diclofenacVille-Veikko Hynninen, Klaus T Olkkola, Kari Leino, et al.
European Journal of Pain (London, England)|November 10, 2009
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamineNora M Hagelberg, Marko A Peltoniemi, Teijo I Saari, et al.
European Journal of Clinical Pharmacology|December 18, 2012
Rifampicin markedly decreases the exposure to oral and intravenous tramadolTuukka Saarikoski, Teijo I Saari, Nora M Hagelberg, et al.
Pageof 20